Everest Medicines Ltd (HKSE:01952)

HK$ 34.8 -1.45 (-4%) Market Cap: 11.22 Bil Enterprise Value: 10.14 Bil PE Ratio: 0 PB Ratio: 2.36 GF Score: 39/100

Q2 2024 Everest Medicines Ltd Earnings Call Transcript
Aug 28, 2024

HK$20.95 (-0.24%)

Earnings
Q4 2023 Everest Medicines Ltd Earnings Call Transcript
Mar 28, 2024

HK$23.5 (+7.31%)

Earnings
Q2 2023 Everest Medicines Ltd Earnings Call (English) Transcript
Aug 24, 2023

HK$17.3 (-3.24%)

Earnings
Q4 2022 Everest Medicines Ltd Earnings Call Transcript
Mar 31, 2023

HK$15.44 (+0.52%)

Earnings
Everest Medicines Ltd New Strategy Launch Call Transcript
Jan 03, 2023
Calliditas Therapeutics AB Fireside Chat with Everest Medicines Ltd Transcript
Dec 14, 2022
Everest Medicines Ltd Business Update Conference Call Transcript
Aug 16, 2022
Full Year 2021 Everest Medicines Ltd Earnings Call Transcript
Mar 29, 2022

HK$21.6 (+2.61%)

Earnings

Full Year 2021 Everest Medicines Ltd Earnings Call Transcript

Mar 29, 2022 / 01:00AM GMT

Release Date Price: HK$21.6 (+2.61%)

Transcript

Operator

Good day, and thank you for standing by. Welcome to the Everest Medicines Full Year 2021 Earnings Conference Call. Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Leah Liu, VP of Corporate Affairs.

Leah Liu

Thank you, operator, and good morning, everyone. Thank you all for joining this call. For this call this morning, we would like to discuss our 2021 full year results and give you an update on our business. The details of the full year results is available on our website. Joining me today from the company are Dr. Kerry Blanchard, our CEO; Ian Woo, our President and CFO; and Neo Zhang, our COO.

Before we get started, I'd like to remind you that the speakers of this conference call may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the company or its officers with respect to the business operations and financial conditions of the company, which can be identified by terminology

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.